01Approach to the Critical Patient/attcp32

Surgical emergency recognition

›Deceptively benign external appearance masking severe internal injury

›Entry wound often a small, innocuous puncture on volar distal phalanx

›Underlying tissue destruction can be devastating regardless of wound size

›Overall historical amputation rate ~28–30% for all HPII

›Amputation rate up to 58% for organic solvent injection

›Time-critical intervention threshold

›Outcomes significantly better when surgical debridement performed within 6 hours of injury

›Delay beyond 6 hours associated with markedly worse amputation and functional outcomes

›Emergent hand surgery consultation required immediately upon recognition

›Do not await imaging results before activating surgical team

Immediate stabilization priorities

›Airway and systemic toxicity assessment

›If volatile solvents injected, risk of systemic absorption and inhalation exposure

›Respiratory symptoms may indicate concurrent inhalation of organic compounds

›ECG monitoring for hydrocarbon-induced arrhythmia risk

›If hemodynamic instability, resuscitate and arrange ICU-level care

›Extremity stabilization

›Immobilize affected extremity in position of function

›Elevate hand above heart level to reduce swelling

›Do not perform digital nerve block in the ED — increases compartment pressure

›IV analgesia preferred for pain control

›Escalation triggers

›Rapidly progressive swelling, pallor, or paresthesia — compartment syndrome

›Loss of capillary refill or absent digital pulses — vascular emergency

›Crepitus or subcutaneous emphysema — extensive fascial plane dissection

›Signs of systemic toxicity — ICU consultation

›Facial, orbital, or neck injection — critical care involvement

02History/hx42

Mechanism of injury

›Device and substance identification

›Device type: paint gun, grease gun, hydraulic equipment, cleaning sprayer, diesel injector

›Injected substance: paint, paint thinner, grease, hydraulic fluid, diesel, water, air, solvent, gasoline

›Device operating pressure in psi — devices generate up to 12,000 psi

›Duration of contact with nozzle (volume of material injected)

›Material Safety Data Sheet from employer — critical for toxicity assessment

›Injury event details

›Exact anatomical site of entry

›Time of injury — surgical outcomes significantly better within 6 hours

›Mechanism: accidental trigger activation, nozzle contact, secondary splash

Symptom progression

›Presenting complaints

›Initial pain at injection site — may be minimal early

›Progressive swelling of digit or hand

›Paresthesia or numbness — neurovascular compromise

›Skin color changes: pallor, blanching, ecchymosis

›Progression of symptoms since time of injury

›Alarm symptoms

›Rapidly progressive swelling suggesting compartment syndrome

›Loss of sensation in the digit

›Absent capillary refill

›Fever or chills suggesting early systemic infection

›Respiratory symptoms if volatile solvents involved

Risk factors and occupational context

›Occupational exposure profile

›Construction workers, painters, mechanics, industrial cleaners, automotive workers

›Iron and steel workers — 61% of cases in one series

03Physical Exam/exam29

Entry wound assessment

›Wound characteristics

›Entry wound location — typically volar surface of distal phalanx of index finger

›Wound size: often small puncture disproportionate to internal injury

›Wound margins: clean puncture vs. stellate vs. avulsion

›Visible foreign material at wound margin

›Crepitus on palpation suggesting subcutaneous emphysema or air injection

Neurovascular examination

›Perfusion and neural status

›Capillary refill time in all digits — normal less than 2 seconds

›Digital Allen test to assess radial and ulnar digital artery patency

›Two-point discrimination for sensory nerve function

›Motor function: flexor and extensor tendon integrity

›Skin color: pallor, mottling, or ecchymosis of digit or hand

›Digital temperature relative to contralateral hand

Compartment and soft tissue assessment

›Compartment syndrome evaluation

›Tense swelling of digit or hand disproportionate to wound size — key clinical sign

›Pain with passive stretch of intrinsic muscles and long flexors

›Skin tightness and firmness on palpation of hand compartments

›Pallor beyond wound distribution

›Compartment pressure measurement if clinical suspicion confirmed

›Extent of material tracking

›Swelling tracking proximally along tendon sheaths or fascial planes

›Erythema or discoloration extending beyond wound

›Tenderness along flexor tendon sheath — Kanavel signs overlap with tenosynovitis

›Subcutaneous emphysema extent by palpation

04Differential Diagnosis/ddx31

Traumatic and mechanical diagnoses

›Simple puncture wound or laceration

›Most common misdiagnosis for HPII

›Differentiating feature: mechanism of high-pressure device involvement

›ICD-10: S60-S69 (superficial injuries and open wounds of wrist and hand)

›Compartment syndrome from other causes

›May develop secondary to HPII or be primary diagnosis

›Differentiating feature: pressure measurement and mechanism history

›ICD-10: M79.A21 (nontraumatic compartment syndrome, right upper extremity)

Infectious diagnoses

›Flexor tenosynovitis

›Kanavel signs: fusiform swelling, flexed posture, tenderness along sheath, pain with passive extension

›May develop as complication of delayed HPII

›ICD-10: M65.14 (other infective (teno)synovitis, hand)

›Cellulitis and abscess

›Erythema, warmth, fluctuance without high-pressure mechanism

›ICD-10: L03.011 (cellulitis of right finger)

›Necrotizing fasciitis

›Delayed HPII presentations may mimic or develop into necrotizing fasciitis

›Rapidly spreading infection, skin necrosis, systemic toxicity

›ICD-10: M72.6 (necrotizing fasciitis)

Other diagnoses

›Envenomation or snakebite

›If mechanism history unclear

›Differentiating feature: exposure history, fang marks, geographic context

›ICD-10: T63.001 (toxic effect of unspecified snake venom)

›Fracture with soft tissue injury

›Mechanism may overlap with crush injury

05Laboratory Tests/lt24

Baseline hematologic and metabolic panels

›Complete blood count

›Baseline white cell count and differential

›Platelet count for surgical planning

›Serial CBC to monitor evolving infection or sepsis

›Basic metabolic panel

›Baseline renal function — monitoring for systemic toxicity from absorbed solvents

›Electrolytes for surgical anesthesia planning

›Glucose — diabetes increases infection risk and worsens outcomes

Infection and inflammatory markers

›C-reactive protein

›Baseline and serial CRP monitoring to assess inflammatory trajectory

›CRP elevation guides need for repeat surgical debridement

›Serial measurements more useful than single values

›Blood cultures

›Obtain if signs of systemic infection, fever, or sepsis physiology

›Polymicrobial contamination expected in industrial injuries

Surgical preparation labs

›Coagulation studies

›PT, INR, aPTT for patients on anticoagulants or with suspected coagulopathy

›Baseline for operative planning

›Type and screen

›If extensive debridement or complex reconstruction anticipated

›Toxicology and organ function monitoring

›Hepatic function panel if volatile organic solvents injected (hepatotoxicity risk)

›Creatinine and urinalysis for nephrotoxicity monitoring

›Carbon monoxide level if combustion products suspected in enclosed space

06Diagnostic Tests/dt37

Scoring Systems

›Prognosis determination in HPII

›No validated scoring system specific to HPII exists

›Prognosis determined by combination of: substance injected, anatomical location, device pressure, and time to debridement

›Highest amputation risk: organic solvents (paint, paint thinner, gasoline, diesel) — rate up to 58%

›Moderate risk: grease, hydraulic oil — amputation rate ~15–28%

›Lower risk: air, water — may be managed conservatively if no compartment syndrome

›Finger injection carries significantly worse prognosis than palm or thumb injection

›Delay to surgical debridement beyond 6 hours is independent risk factor for worse outcome

MRI

›MRI hand and wrist

›Not routinely obtained preoperatively due to surgical urgency

›Demonstrates anatomic distribution of foreign material along fascial planes and tendon sheaths

›Associated soft tissue and osseous injury characterization

›Peculiar MRI features: fluid signal tracts following tendon sheath anatomy

›May aid surgical planning in complex or delayed presentations

›T1: foreign material may appear hypointense or variable depending on substance

›T2/STIR: edema, fluid tracking, and tissue necrosis zones

›Do not delay surgical consultation to obtain MRI

CT

›CT indications for HPII

›Not routine for isolated hand injury — plain radiograph is first-line

›CT upper extremity: complex injuries with uncertain extent of material spread

›CT face, neck, orbit: facial or orbital injection injuries for anatomic delineation

›CT chest: if inhalation injury or thoracic involvement suspected

›Demonstrates: extent of subcutaneous emphysema, radiopaque foreign material, fascial plane dissection

›CT should not delay surgical consultation or operative intervention

07Disposition/dispo22

Admission criteria

›Indications for admission

›All patients with confirmed liquid material injection (paint, grease, solvent, hydraulic fluid, diesel) require admission for surgical management

›Surgical debridement ideally performed within 6 hours of injury

›Average hospitalization ~4 days (range 1–9 days)

›All patients require hand surgery consultation regardless of injury severity

›ICU-level admission indications

›Complex facial, orbital, or neck injection with airway or neurovascular risk

›Systemic toxicity from absorbed hydrocarbons

›Hemodynamic instability

›Extensive fascial plane dissection with compartment syndrome

Conservative management criteria

›Criteria for observation without immediate surgery

›Air, gas, or small-volume water injection without compartment syndrome

›Veterinary vaccine injection without compartment syndrome or neurovascular compromise

›Serial neurovascular exams every 2 hours

›Low-threshold for surgical conversion if symptoms progress

›Hand surgery consultation still mandatory

Transfer criteria

›Transfer indications

›No hand surgery capability at receiving facility

›Transfer within 6-hour window for optimal outcomes

›Stabilize and transfer — do not delay for extensive workup

›Document neurovascular status before and after transfer

›Occupational medicine referral for workers compensation and return-to-work planning

08Treatment/t51

Initial ED management

›Immediate stabilization bundle

›Immobilize affected extremity in position of function

›Elevate hand above heart level

›IV access and analgesia

›Opioid IV analgesia for pain control

›Avoid digital nerve blocks — increase compartment pressure

›Avoid local wound infiltration as definitive anesthesia

›NPO status for pending surgical intervention

Antibiotics

›Broad-spectrum IV antibiotic regimen

›Initiate immediately in ED without delay

›First-generation cephalosporin: cefazolin 1–2 g IV every 8 hours

›Covers gram-positive organisms and common skin flora

›Adjust dose for renal impairment

›Add aminoglycoside for polymicrobial or gram-negative coverage

›Gentamicin 5 mg/kg IV once daily (or 1.5 mg/kg IV every 8 hours)

›Monitor renal function

›Beta-lactam allergy alternative: clindamycin 600–900 mg IV every 8 hours

›Duration: continue perioperatively and postoperatively based on wound findings

Tetanus prophylaxis

›Tetanus prevention protocol

›Tetanus toxoid if immunization not current or unknown

›0.5 mL IM deltoid

›Tetanus immunoglobulin (TIG) if unvaccinated or incomplete series

›TIG 250 units IM contralateral site from toxoid

›Document prior vaccination history

09Special Populations/sp47

Pregnancy

›Physiologic considerations in pregnancy

›HPII in pregnancy is extremely rare — no large series exist

›Increased hand edema of pregnancy may confound swelling assessment

›Multidisciplinary management: hand surgery, obstetrics, anesthesia

›Medication safety

›Tetanus toxoid: safe in all trimesters (Category C, widely used)

›Tetanus immunoglobulin: safe in pregnancy

›Antibiotic selection: cefazolin safe in pregnancy (Category B)

›Avoid aminoglycosides if possible — ototoxicity risk to fetus

›Clindamycin acceptable alternative (Category B)

›Opioid analgesia: use minimum effective dose, monitor fetal heart rate

›Corticosteroids: use with caution; may elevate glucose in gestational diabetes

›Surgical considerations

›General anesthesia risk in pregnancy — coordinate with obstetrics

›Regional anesthesia preferred when technically feasible

›Fetal monitoring perioperatively in viable gestations

›Surgical urgency is not reduced by pregnancy — delay increases amputation risk

Geriatric

›Age-related physiologic changes

›Reduced peripheral perfusion at baseline — worsens ischemic injury from compartment compression

›Impaired wound healing from reduced collagen synthesis and immune function

›Higher prevalence of peripheral vascular disease and diabetes — independent risk factors for amputation

›Reduced hand function at baseline — functional goals of treatment may differ

›Medication considerations

›Aminoglycosides: increased nephrotoxicity risk — use once-daily dosing with level monitoring

›Opioid analgesia: risk of delirium and respiratory depression — use lowest effective dose

›Renal dose adjustment for cefazolin if CrCl reduced

10Background/b58

Epidemiology

›Incidence and population data

›HPII is a rare but well-recognized occupational hand injury

›Construction workers, painters, mechanics, iron workers represent the highest-risk occupations

›~61% of cases involve industrial/iron and steel workers in some series

›Male sex accounts for nearly 100% of all reported cases

›Typical age at presentation: mid-30s to early 40s

›Nondominant hand involved in ~63% of cases — the hand positioned near the nozzle

›Index finger distal phalanx is the most common anatomical site

›Outcome data

›Overall historical amputation rate: ~28–30%

›Organic solvent injection amputation rate: up to 58%

›Grease or hydraulic fluid injection amputation rate: ~15–28%

›Air or water injection: much lower amputation rate with appropriate management

›Average hospitalization: ~4 days (range 1–9 days)

›Average number of debridement procedures: ~1.8 per patient

›Average follow-up duration in studies: ~69 days

›Most patients have residual sequelae: stiffness, chronic pain, sensory loss

›Many patients unable to return to prior occupation

Pathophysiology

›Three mechanisms of tissue destruction

›Direct mechanical injury from high-pressure jet

›Devices generate pressures up to 12,000 psi

›Pressure forces material along fascial planes and tendon sheaths

›Fascial anatomy dictates proximal spread of injected material

›Chemical toxicity of injected material

›Organic solvents cause lipid dissolution and direct cellular necrosis

›Grease and oil cause foreign body granulomatous inflammatory reaction

›Air and water: least toxic, primarily mechanical injury

›Vascular compromise

›Increased compartment pressure compresses digital vessels

›Vasospasm from chemical irritation of vessel walls

›Ischemia leads to tissue necrosis if not rapidly decompressed

›Anatomical spread patterns

›Material follows path of least resistance: tendon sheaths, fascial planes

›Flexor tendon sheaths connect digits to carpal tunnel and forearm

›Thenar and hypothenar compartments at risk from palmar injection

›Facial and orbital injection can track along deep fascial planes into neck and thorax

Therapeutic Considerations

›Timing of intervention — most critical prognostic factor

›Surgical debridement within 6 hours: significantly better outcomes

›Each hour of delay allows continued chemical tissue destruction and vascular compromise

›No role for watchful waiting in liquid material injection injuries

›Substance-specific management

›Organic solvents: highest priority for emergent wide debridement

›Grease/hydraulic fluid: emergent debridement, thorough irrigation

›Air/gas/water: may be managed with observation ± antibiotics if no compartment syndrome

›Surgical principles

›Wide excision preferred over limited debridement — residual material perpetuates inflammation

›Serial debridement planned from outset — single procedure rarely sufficient for liquid materials

›Wound left open to allow drainage and reassessment

›Delayed primary closure or split-thickness skin grafting

›Corticosteroid evidence

›Theoretical benefit: reduce inflammatory cascade from chemical injury

›Large retrospective review: no impact on amputation rate or infection incidence

›Not standard of care; individualized use only

›Evidence base

›Primary literature: retrospective case series and case reports

›No randomized controlled trials exist given rarity of injury

›EMJ 2025 practice review provides current emergency medicine guidance

›J Clin Med 2019 multicentric retrospective: management outcomes data

11Patient Discharge Instructions/pdi31

copy discharge instructions

›High-Pressure Injection Injury — Discharge Instructions

›You have been treated for a high-pressure injection injury to your hand or finger

›This is a serious injury that requires close follow-up with a hand surgery specialist

›Even if your wound looks small, significant internal damage may have occurred

›Wound care at home

›Keep the wound clean and dry as instructed by your surgical team

›Change dressings as directed — do not allow the wound to become soaked

›Elevate your hand above heart level when resting to reduce swelling

›Do not apply pressure or squeeze the wound

›Activity restrictions

›No heavy lifting or gripping with the injured hand until cleared by your surgeon

›No return to work with high-pressure equipment until fully healed and surgeon-approved

›Wear hand therapy splint or protective device as prescribed

›Attend all scheduled hand therapy appointments

›Medications

›Take all prescribed antibiotics for the full course — do not stop early

›Take pain medication as prescribed — do not exceed recommended doses

›Take tetanus booster if provided and ensure your records are updated

›Return to emergency department immediately if you develop

›Increasing pain, swelling, or redness in the hand or finger

›Numbness, tingling, or weakness in any finger

›Loss of color in the finger — white, blue, or purple discoloration

›Fever greater than 38.5 degrees Celsius or chills

›Wound drainage, pus, or foul smell from the wound

›Rapid worsening of any symptoms

›Follow-up

›Hand surgery follow-up within 48–72 hours of discharge — do not miss this appointment

12References/r23

Guidelines and key sources

›Cornely RM, Abbott EN, Gutama B, et al. Recognising High-Pressure Injection Injuries to the Hand: A Practice Review With Guidance for Emergency Physicians. Emergency Medicine Journal. 2025. PMID 40588328

›Current emergency medicine practice review with management guidance

›Amputation rate data, time-to-surgery outcomes, substance risk stratification

›Vitale E, Ledda C, Adani R, et al. Management of High-Pressure Injection Hand Injuries: A Multicentric, Retrospective, Observational Study. Journal of Clinical Medicine. 2019. PMID 31744068

›Multicentric retrospective study; surgical management protocols and outcomes

›Antibiotic regimens, tetanus, corticosteroid use analyzed

›Hogan CJ, Ruland RT. High-Pressure Injection Injuries to the Upper Extremity: A Review of the Literature. Journal of Orthopaedic Trauma. 2006. PMID 16891944

›Comprehensive literature review; epidemiology, occupational demographics, outcome data

›Nondominant hand prevalence 63%, male predominance, average hospitalization data

›Amsdell SL, Hammert WC. High-Pressure Injection Injuries in the Hand: Current Treatment Concepts. Plastic and Reconstructive Surgery. 2013. PMID 24076706

›Substance-specific amputation rates; surgical treatment principles

›Cannon TA. High-Pressure Injection Injuries of the Hand. Orthopedic Clinics of North America. 2016. PMID 27241384

›Conservative vs surgical management criteria; air and water injection management

›Pertea M, Luca S, Benamor M, et al. High-Pressure Injection Injury of the Hand — a Rare but True Surgical Emergency. Journal of Clinical Medicine. 2024. PMID 39797154

›Recent series; CRP monitoring for repeat debridement guidance; CT for complex injuries

›Collins M, McGauvran A, Elhassan B. High-Pressure Injection Injury of the Hand: Peculiar MRI Features and Treatment Implications. Skeletal Radiology. 2019. PMID 29909479

›MRI signal characteristics and anatomic distribution of injected material

›Nichols G, Gallegos J, Tavana ML, Armstrong MB, Herrera FA. High-Pressure Injection Injuries of the Hand: A 10-Year Retrospective Analysis at a Single Academic Center. Annals of Plastic Surgery. 2021. PMID 33833159

›Single-center 10-year series; MSDS importance, occupational context

›Rosenwasser MP, Wei DH. High-Pressure Injection Injuries to the Hand. Journal of the American Academy of Orthopaedic Surgeons. 2014. PMID 24382878

›AAOS review; surgical principles and prognosis by substance

›Rodríguez-Villar S, Kennedy RC, Dall'Antonia M, Menichetti CP. Management of Industrial High-Pressure Fluid Injection Injuries: The Water Jetting Association Experience With Water Driven Injuries. European Journal of Trauma and Emergency Surgery. 2019. PMID 30895338

›Water-specific injury management; conservative management criteria for low-risk cases

Evidence & Review

Evidence & Review